Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-25 @ 10:56 PM
Study NCT ID:
NCT04718467
Status:
WITHDRAWN
Last Update Posted:
2021-05-25
First Post:
2021-01-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells)
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-05-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-03-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-20
First Submit QC Date:
None
Study First Post Date:
2021-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-21
Last Update Post Date:
2021-05-25
Last Update Post Date Type:
ACTUAL